A new approach to understanding racial disparities in prostate cancer treatment

Journal of Geriatric Oncology

Volumn 4, Issue 1, 2013, Pages 1-8

  Presley, Carolyn J ^a,b   Raldow, Ann C ^a   Cramer, Laura D ^a   Soulos, Pamela R ^a,b   Long, Jessica B ^a,b   Yu, James B ^a,b   Makarov, Danil V ^a,c   Gross, Cary P ^a,b  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Geriatrics; Healthcare disparities; Minority health; Population; Prostatic neoplasms; Standard of care

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CAUCASIAN; CONTROLLED STUDY; DISEASE ACTIVITY; EXTERNAL BEAM RADIOTHERAPY; HEALTH DISPARITY; HUMAN; LIFE EXPECTANCY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STATISTICAL MODEL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTHCARE DISPARITIES; HUMANS; MALE; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84872606072     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2012.07.005     Document Type: Article

References (36)

1. Bach P.B., Schrag D., Brawley O.W., Galaznik A., Yakren S., Begg C.B. Survival of blacks and whites after a cancer diagnosis. J Am Med Assoc 2002, 287:2106-2113.
2. Virnig B.A., Baxter N.N., Habermann E.B., Feldman R.D., Bradley C.J. A matter of race: early-versus late-stage cancer diagnosis. Health Aff 2009, 28:160-168.
3. Ward E., Jemal A., Cokkinides V., Singh G.K., Cardinez C., Ghafoor A., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004, 54:78-93.
4. Shavers V.L., Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002, 94:334-357.
5. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
6. Gross C.P., Smith B.D., Wolf E., Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?. Cancer 2008, 112:900-908.
7. Underwood W., DeMonner S., Ubel P., Fagerlin A., Sanda M.G., Wei J.T. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 2004, 171:1504-1507.
8. Zeliadt S.B., Potosky A.L., Etzioni R., Ramsey S.D., Penson D.F. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-medicare trends 1991 to 1999. Urology 2004, 64:1171-1176.
9. Scardino P. Update: NCCN prostate cancer clinical practice guidelines. J Natl Compr Canc Netw 2005, 3.
10. Roberts C.B., Albertsen P.C., Shao Y., Moore D.F., Mehta A.R., Stein M.N., et al. Patterns and correlates of prostate cancer treatment in older men. Am J Med 2011, 124:235-243.
11. Hoffman R.M., Harlan L.C., Klabunde C.N., Gilliland F.D., Stephenson R.A., Hunt W.C., et al. Racial differences in initial treatment for clinically localized prostate cancer. J Gen Intern Med 2003, 18:845-853.
12. Barocas D.A., Penson D.F. Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap. BJU Int 2010, 106:322-328.
13. Harlan L., Brawley O., Pommerenke F., Wali P., Kramer B. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 1995, 13:93-100.
14. Underwood W., Jackson J., Wei J.T., Dunn R., Baker E., DeMonner S., et al. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 2005, 103:538-545.
15. U.S.Preventive Services Task Force Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2008, 149:185-191.
16. Miller D.C., Gruber S.B., Hollenbeck B.K., Montie J.E., Wei J.T. Incidence of initial local therapy among men with lower-risk prostate cancer in the united states. J Natl Cancer Inst 2006, 98:1134-1141.
17. Bill-Axelson A., Holmberg L., Ruutu M., Garmo H., Stark J.R., Busch C., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011, 364:1708-1717.
18. Cooperberg M.R., Konety B.R. Management of localized prostate cancer in men over 65years. Curr Opin Urol 2009, 19:309-314.
19. Cooperberg M.R., Lubeck D.P., Meng M.V., Mehta S.S., Carroll P.R. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004, 22:2141-2149.
20. Kattan M.W., Cowen M.E., Miles B.J. A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med May 1997, 12(5):299-305.
21. Carroll P.R. Early stage prostate cancer-do we have a problem with over-detection, overtreatment or both?. J Urol 2005, 173:1061-1062.
22. Altekruse S.F., Kosary C.L., Krapcho M., Neyman N., Aminou R., Waldron W., et al. SEER Cancer Statistics Review 2007, National Cancer Institute, Bethesda, MD, Available from URL: http://seer.cancer.gov/csr/1975_2007/.
23. Warren J.L., Klabunde C., Schrag D., Bach P.B., Riley G.F. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care Aug. 2002, 40(8 Suppl.):IV-3-IV-18. [http://www.ncbi.nlm.nih.gov/pubmed/12187163].
24. SEER Registry Groupings for Analyses. Surveillance Epidemiology and End Results. National Cancer Institute., http://seer.cancer.gov/registries/terms.html.
25. Elixhauser A., Steiner C., Harris D.R., Coffey R.M. Comorbidity measures for use with administrative data. Med Care 1998, 36:8-27.
26. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D.H., Sanders M., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst September 7 2005, 97:1248-1253.
27. Goodwin J.S., Hunt W.C., Key C.R., Samet J.M. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA 1987, 258:3125-3130.
28. Samet J., Hunt W.C., Key C., Humble C.G., Goodwin J.S. Choice of cancer therapy varies with age of patient. JAMA 1986, 255:3385-3390.
29. Cooperberg M.R., Broering J.M., Carroll P.R. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010, 28:1117-1123.
30. Farjah F., Wood D.E., Yanez N.D., Vaughan T.L., Gaston-Symons R., Krishnadasan B., et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg 2009, 144:14-18.
31. Halbert C.H., Weathers B., Delmoor E., Mahler B., Coyne J., Thompson H.S., et al. Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer 2009, 115:2553-2561.
32. Epstein A.M., Weissman J.S., Schneider E.C., Gatsonis C., Leape L.L., Piana R.N. Race and gender disparities in rates of cardiac revascularization do they reflect appropriate use of procedures or problems in quality of care?. Med Care 2003, 41:1240-1255.
33. Schneider E.C., Leape L.L., Weissman J.S., Piana R.N., Gatsonis C., Epstein A.M. Racial differences in cardiac revascularization rates: does "overuse" explain higher rates among white patients?. Ann Intern Med 2001, 135:328-337.
34. Epstein A.M., Ayanian J.Z., Keogh J.H., Noonan S.J., Armistead N., Cleary P.D., et al. Racial disparities in access to renal transplantation: clinically appropriate or due to underuse or overuse?. N Engl J Med 2000, 343:1537-1544.
35. Weiss T., Weinberger M.I., Holland J., Nelson C., Moadel A. Falling through the cracks: a review of psychological distress and psychosocial service needs in older Black and Hispanic patients with cancer. J Geriatr Oncol April 1 2012, 3(2):163-173.
36. Gironés R., Torregrosa D., Maestu I., Gómez-Codina J., Tenias J.M., Costa R.R. Comprehensive Geriatric Assessment (CGA) of elderly lung cancer patients: a single-center experience. J Geriatr Oncol April 1 2012, 3(2):98-103.